Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Ross

Showing results (81-90 of 800) with videos related to

Pageof 80
Sort By:
JAMA|August 18, 2016
Open Access Platforms for Sharing Clinical Trial DataJoseph S Ross, Harlan M Krumholz
JAMA|May 29, 2014
Trial evidence and approval of therapeutic agents--replyNicholas S Downing, Joseph S Ross
JAMA Internal Medicine|October 6, 2015
No Time to WaitJoseph S Ross, Mitchell H Katz
JAMA Internal Medicine|March 5, 2019
Communicating, and Justifying, Nonefficacy Benefits for New Drugs Approved on the Basis of Noninferiority TrialsJoseph S Ross, Christina C Wee
JAMA|January 28, 2026
AI Use in Research and the Need for Continued GuidancePreeti N Malani, Joseph S Ross
JAMA Internal Medicine|May 12, 2015
On Chlorofluorocarbon Bans and Inhaled Albuterol PricesJoseph S Ross, Rita F Redberg
JAMA|October 23, 2008
Comparison of the US and Canadian health care systems: a tale of 2 Mount Sinai'sJoseph S Ross, Allan S Detsky
JAMA|October 13, 2011
A model for dissemination and independent analysis of industry dataHarlan M Krumholz, Joseph S Ross
BMJ (Clinical Research Ed.)|January 27, 2018
Bringing Vioxx back to marketJoseph S Ross, Harlan M Krumholz
JAMA Internal Medicine|August 21, 2023
Medical Product Industry Ties to Patient Advocacy Organizations' Executive LeadershipShamik Bhat, Joseph S Ross, Reshma Ramachandran
Pageof 80

Showing results (81-90 of 800) with videos related to

Sort By:
Pageof 80
JAMA|August 18, 2016
Open Access Platforms for Sharing Clinical Trial DataJoseph S Ross, Harlan M Krumholz
JAMA|May 29, 2014
Trial evidence and approval of therapeutic agents--replyNicholas S Downing, Joseph S Ross
JAMA Internal Medicine|October 6, 2015
No Time to WaitJoseph S Ross, Mitchell H Katz
JAMA Internal Medicine|March 5, 2019
Communicating, and Justifying, Nonefficacy Benefits for New Drugs Approved on the Basis of Noninferiority TrialsJoseph S Ross, Christina C Wee
JAMA|January 28, 2026
AI Use in Research and the Need for Continued GuidancePreeti N Malani, Joseph S Ross
JAMA Internal Medicine|May 12, 2015
On Chlorofluorocarbon Bans and Inhaled Albuterol PricesJoseph S Ross, Rita F Redberg
JAMA|October 23, 2008
Comparison of the US and Canadian health care systems: a tale of 2 Mount Sinai'sJoseph S Ross, Allan S Detsky
JAMA|October 13, 2011
A model for dissemination and independent analysis of industry dataHarlan M Krumholz, Joseph S Ross
BMJ (Clinical Research Ed.)|January 27, 2018
Bringing Vioxx back to marketJoseph S Ross, Harlan M Krumholz
JAMA Internal Medicine|August 21, 2023
Medical Product Industry Ties to Patient Advocacy Organizations' Executive LeadershipShamik Bhat, Joseph S Ross, Reshma Ramachandran
Pageof 80